BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2007
View Archived Issues
Recent Sumitomo Chemical patents disclose novel therapeutic agents for chronic renal failure
Read More
Omega-3 fatty acids may prevent development of psychosis in at-risk adolescents
Read More
Biological mechanism of treatment response with gene therapy for Parkinson's disease
Read More
Single-agent activity seen with perifosine in malignant gliomas
Read More
Pooled data show efficacy of desvenlafaxine in depression across ages, genders
Read More
Recent Memory and AstraZeneca patents describe new antidepressive and antipsychotic agents
Read More
Novel therapeutic agents for cardiovascular diseases disclosed in recent patents
Read More
Anti-CD22 agent plus chemotherapy yields positive preclinical results in pre-B ALL
Read More
Dock-and-lock-generated dimeric interferon shows potential in cancer therapy
Read More
Epratuzumab/rituximab combination active in recurrent non-Hodgkin's lymphoma
Read More
New data presented on lymphoma treatment with rituximab and mitumprotimut-T
Read More
Phosphagenics reports positive results from a phase I clinical trial of TPM and oxycodone
Read More
Oxford Genome Sciences and Amgen enter collaboration for therapeutic antibodies in cancer
Read More
Novelos enters license agreement with Lee's Pharmaceutical for NOV-002 and NOV-205
Read More
Clinical Data initiates long-term safety and tolerability study of vilazodone for depression
Read More
Cytopia initiates phase II trial of anticancer vascular-disrupting agent CYT-997
Read More
Lilly acquires worldwide rights to BioMS Medical's MBP-8298 for multiple sclerosis
Read More
Aspreva shareholders approve acquisition by Galenica
Read More
Synthetic Blood finalizes Oxycyte phase IIb clinical trial protocol for traumatic brain injury
Read More
Commencement of phase II clinical trial of ZymoGenetics' IL-21 in metastatic melanoma
Read More
Innocoll initiates dosing in phase II clinical trial of CollaRx gentamicin topical for foot ulcers
Read More
GenVec receives NIH funding for gene-based drug therapy to treat severe balance disorders
Read More
Schering-Plough reports positive results from study of asenapine for acute schizophrenia
Read More
FDA grants orphan drug designation to Insmed's Iplex for myotonic muscular dystrophy
Read More
FDA approves new mechanism of action labeling for CV Therapeutics' Ranexa for angina
Read More
AMAG Pharmaceuticals submits NDA to FDA for ferumoxytol for chronic kidney disease
Read More
FDA issues nonapprovable letter for Indevus' Valstar
Read More
GSK submits NDA to FDA for Promacta for idiopathic thrombocytopenic purpura
Read More